BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33671331)

  • 1. Gene Regulatory Network of ETS Domain Transcription Factors in Different Stages of Glioma.
    Babal YK; Kandemir B; Kurnaz IA
    J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33671331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.
    Mesquita D; Barros-Silva JD; Santos J; Skotheim RI; Lothe RA; Paulo P; Teixeira MR
    Oncotarget; 2015 Mar; 6(7):5217-36. PubMed ID: 25595908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function and regulation of the PEA3 subfamily of ETS transcription factors in cancer.
    Qi T; Qu Q; Li G; Wang J; Zhu H; Yang Z; Sun Y; Lu Q; Qu J
    Am J Cancer Res; 2020; 10(10):3083-3105. PubMed ID: 33163259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis.
    Kurpios NA; Sabolic NA; Shepherd TG; Fidalgo GM; Hassell JA
    J Mammary Gland Biol Neoplasia; 2003 Apr; 8(2):177-90. PubMed ID: 14635793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
    Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
    Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PEA3 group of ETS-related transcription factors. Role in breast cancer metastasis.
    de Launoit Y; Chotteau-Lelievre A; Beaudoin C; Coutte L; Netzer S; Brenner C; Huvent I; Baert JL
    Adv Exp Med Biol; 2000; 480():107-16. PubMed ID: 10959416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors.
    Monté D; Baert JL; Defossez PA; de Launoit Y; Stéhelin D
    Oncogene; 1994 May; 9(5):1397-406. PubMed ID: 8152800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ETV4 overexpression promotes progression of non-small cell lung cancer by upregulating PXN and MMP1 transcriptionally.
    Wang Y; Ding X; Liu B; Li M; Chang Y; Shen H; Xie SM; Xing L; Li Y
    Mol Carcinog; 2020 Jan; 59(1):73-86. PubMed ID: 31670855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the human and mouse ETV1/ER81 transcription factor genes: role of the two alternatively spliced isoforms in the human.
    Coutte L; Monté D; Imai K; Pouilly L; Dewitte F; Vidaud M; Adamski J; Baert JL; de Launoit Y
    Oncogene; 1999 Nov; 18(46):6278-86. PubMed ID: 10597226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors.
    Galang CK; Muller WJ; Foos G; Oshima RG; Hauser CA
    J Biol Chem; 2004 Mar; 279(12):11281-92. PubMed ID: 14662758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells.
    Baert JL; Monté D; Musgrove EA; Albagli O; Sutherland RL; de Launoit Y
    Int J Cancer; 1997 Mar; 70(5):590-7. PubMed ID: 9052761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse Elk oncogene maps to chromosome X and a novel Elk oncogene (Elk3) maps to chromosome 10.
    Tamai Y; Taketo M; Nozaki M; Seldin MF
    Genomics; 1995 Mar; 26(2):414-6. PubMed ID: 7601474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ETS-Domain Transcription Factor Elk-1 Regulates Stemness Genes in Brain Tumors and CD133+ BrainTumor-Initiating Cells.
    Sogut MS; Venugopal C; Kandemir B; Dag U; Mahendram S; Singh S; Gulfidan G; Arga KY; Yilmaz B; Kurnaz IA
    J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33672811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structured and disordered regions cooperatively mediate DNA-binding autoinhibition of ETS factors ETV1, ETV4 and ETV5.
    Currie SL; Lau DKW; Doane JJ; Whitby FG; Okon M; McIntosh LP; Graves BJ
    Nucleic Acids Res; 2017 Mar; 45(5):2223-2241. PubMed ID: 28161714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
    Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
    Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription.
    El-Tanani M; Platt-Higgins A; Rudland PS; Campbell FC
    J Biol Chem; 2004 May; 279(20):20794-806. PubMed ID: 14990565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ETV4 and AP1 Transcription Factors Form Multivalent Interactions with three Sites on the MED25 Activator-Interacting Domain.
    Currie SL; Doane JJ; Evans KS; Bhachech N; Madison BJ; Lau DKW; McIntosh LP; Skalicky JJ; Clark KA; Graves BJ
    J Mol Biol; 2017 Oct; 429(20):2975-2995. PubMed ID: 28728983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles and regulations of the ETS transcription factor ELF4/MEF.
    Suico MA; Shuto T; Kai H
    J Mol Cell Biol; 2017 Jun; 9(3):168-177. PubMed ID: 27932483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant-negative inhibition of Ets 1 suppresses tumor growth, invasion and migration in rat C6 glioma cells and reveals differentially expressed Ets 1 target genes.
    Sahin A; Vercamer C; Kaminski A; Fuchs T; Florin A; Hahne JC; Mattot V; Pourtier-Manzanedo A; Pietsch T; Fafeur V; Wernert N
    Int J Oncol; 2009 Feb; 34(2):377-89. PubMed ID: 19148472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the promoter of the type II transforming growth factor-beta receptor gene.
    Kopp JL; Wilder PJ; Desler M; Kim JH; Hou J; Nowling T; Rizzino A
    J Biol Chem; 2004 May; 279(19):19407-20. PubMed ID: 14976186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.